Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Fournier investigates deoxyspergualin analogues

Oct. 4, 1996

Enzyme inhibitor for autoimmune diseases isolated by Japanese researchers

Oct. 4, 1996

Mercian investigators report new antiarthritic compounds

Oct. 4, 1996

Merck Frosst discloses a new series of COX-2 inhibitors

Oct. 4, 1996

Matrix metalloproteinase inhibitors disclosed by Roche Bioscience

Oct. 4, 1996

More COX-2 inhibitors from Searle

Oct. 4, 1996

Dana Farber discloses unique antiherpetic therapy

Oct. 4, 1996

Antiherpesvirus agents from Eisai

Oct. 4, 1996

Pharmacia & Upjohn continues investigation of oxazolidinones

Oct. 4, 1996

Takeda discloses cephem antibacterial compounds

Oct. 4, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 1, 2026.
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...